Page 170 - Liver Diseases in Children

160 โรคตับในเด็ก

pthaigastro.org
12. Merle U, Schaefer M, Ferenci P, Stremmel W. Clinical presentation, diagnosis and long-term outcome
of Wilson’s disease: a cohort study. Gut 2007;56:115-20.
13. Socha P, Janczyk W, Dhawan A, Baumann U, D’Antiga L, Tanner S, et al. Wilson’s disease in children:
A Position Paper by the Hepatology Committee of the European Society for Paediatric Gastroenterology,

Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2018;66:334-44.
14. Walshe JM. The acute haemolytic syndrome in Wilson’s disease--a review of 22 patients. QJM
2013;106:1003-8.
15. Ferenci P, Caca K, Loudianos G, Mieli-Vergani G, Tanner S, Sternlieb I, et al. Diagnosis and phenotypic
classification of Wilson disease. Liver Int 2003;23:139-42.
16. Koppikar S, Dhawan A. Evaluation of the scoring system for the diagnosis of Wilson’s disease in
children. Liver Int 2005;25:680-1.
17. Yang X, Tong DJ, Liang J, Zhang YH, Lei JH, He XE, et al. Ceruloplasmin level of patients with liver
disease in China. Zhonghua Nei Ke Za Zhi 2005;44:13-5.
18. Steindl P, Ferenci P, Dienes HP, Grimm G, Pabinger I, Madl C, et al. Wilson’s disease in patients
presenting with liver disease: a diagnostic challenge. Gastroenterology 1997;113:212-8.
19. Nicastro E, Ranucci G, Vajro P, Vegnente A, Iorio R. Re-evaluation of the diagnostic criteria for Wilson
disease in children with mild liver disease. Hepatology 2010;52:1948-56.
20. Yang X, Tang XP, Zhang YH, Luo KZ, Jiang YF, Luo HY, et al. Prospective evaluation of the diagnostic
accuracy of hepatic copper content, as determined using the entire core of a liver biopsy sample.

Hepatology 2015;62:1731-41.
21. Sintusek P, Dhawan A. Liver copper estimation: does liver biopsy size really matter? Hepatology
2016;64:1381-2.
22. Sintusek P, Kyrana E, Dhawan A. Utility of serum zinc level to predict severity of Wilson disease.
Hepatology 2016;64:276A.
23. Korman JD, Volenberg I, Balko J, Webster J, Schiodt FV, Squires RH, Jr., et al. Screening for Wilson
disease in acute liver failure: a comparison of currently available diagnostic tests. Hepatology 2008;48:1167-74.
24. Sallie R, Katsiyiannakis L, Baldwin D, Davies S, O’Grady J, Mowat A, et al. Failure of simple biochemical
indexes to reliably differentiate fulminant Wilson’s disease from other causes of fulminant liver failure.
Hepatology 1992;16:1206-11.
25. Sintusek P, Dhawan A. Aberrance of serum zinc and free copper level in Wilson disease. J Pediatr
Gastroenterol Nutr 2016;62:e46.
26. Weiss KH, Thurik F, Gotthardt DN, Schafer M, Teufel U, Wiegand F, et al. Efficacy and safety of oral
chelators in treatment of patients with Wilson disease. Clin Gastroenterol Hepatol 2013;11:1028-35.e1-2.
27. Taylor RM, Chen Y, Dhawan A. Triethylene tetramine dihydrochloride (trientine) in children with Wilson
disease: experience at King’s College Hospital and review of the literature. Eur J Pediatr 2009;168:1061-8.